Revised announcement with reference to the resignation of the CEO along with his letter of resignation
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
EP Biocomposites has filed a revised announcement regarding the resignation of its Chief Executive Officer, Mr. Anand Menon, effective from the close of business hours on November 14, 2024. Mr. Menon cited personal reasons for his departure and the stock exchange had asked the company to attach his resignation letter along with the disclosure. The original intimation of his resignation was made earlier, and this is an updated filing to include the resignation letter as required under SEBI's listing regulations. No successor has been announced in this filing.
This is a procedural update attaching the CEO's resignation letter; the resignation itself is not new news and was already disclosed. For shareholders, the key concern would be the timing of a CEO replacement, but no immediate governance red flags are evident from this filing.